The Labor Market Impacts of GLP-1s

b__d1 pts1 comments

The Labor Market Impacts of GLP-1s | NBER

Skip to main content

Search

Search

The Labor Market Impacts of GLP-1s

N. Meltem Daysal,

Camille JH. Fredrickson,

Ida L. Kristiansen,

Mircea Trandafir

& Jonathan Zhang

Share

LinkedIn

Facebook

Bluesky

Threads

Email

Link

Working Paper 35475

DOI 10.3386/w35475

Issue Date July 2026

We estimate the causal impacts of GLP-1 treatment on labor market outcomes using linked Danish administrative data and a matched stacked difference-in-differences design. We compare patients who initiate GLP-1 treatment during the first two years of Semaglutide availability to observably similar patients who initiate four years later. We find that GLP-1 treatment reduces long-term sickness leave by 17.3%. We estimate total fiscal benefits of GLP-1 initiation of approximately 1.3–1.5% of annual labor income per employed individual. We do not detect statistically significant or economically meaningful impacts on income, labor force participation, or employment over four years.

Acknowledgements and Disclosures

We are grateful for comments provided by Anders Humlum, Matthew Notowidigdo, and Franziska Valder. The activities of CEBI are financed by the Danish National Research Foundation, Grant DNRF134. The authors bear sole responsibility for the content of this paper. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

Citation and Citation Data

Copy Citation

N. Meltem Daysal, Camille JH. Fredrickson, Ida L. Kristiansen, Mircea Trandafir, and Jonathan Zhang, "The Labor Market Impacts of GLP-1s," NBER Working Paper 35475 (2026), https://doi.org/10.3386/w35475.

Copy to Clipboard

Download Citation

MARC

RIS

BibTeΧ

Download Citation Data

Related

Topics

Public Economics

National Fiscal Issues

Health, Education, and Welfare

Health

Programs

Economics of Aging

Economics of Health

Labor Studies

Public Economics

Productivity, Innovation, and Entrepreneurship

Mentioned in the News

GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds

July 21, 2026

Source:

CBS News

Read the research here.

More from the NBER

In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Health, and the Bulletin on Entrepreneurship — as well as online conference reports, video lectures, and interviews.

2025, 17th Annual Feldstein Lecture, N. Gregory Mankiw," The Fiscal Future"

Feldstein Lecture

Presenter:

N. Gregory Mankiw

N. Gregory Mankiw, Robert M. Beren Professor of Economics at Harvard University, presented the 2025 Martin Feldstein...

2025, Methods Lecture, Raj Chetty and Kosuke Imai, "Uncovering Causal Mechanisms: Mediation Analysis and Surrogate Indices"

Methods Lectures

Presenters:

Raj Chetty

& Kosuke Imai

SlidesBackground materials on mediationImai, Kosuke, Dustin Tingley, and Teppei Yamamoto. (2013). “Experimental Designs...

2025, International Trade and Macroeconomics, "Panel on The Future of the Global Economy"

Panel Discussion

Presenters:

Oleg Itskhoki,

Paul R. Krugman

& Linda Tesar

Supported by the Alfred P. Sloan Foundation grant #G-2023-19633, the Lynde and Harry Bradley Foundation grant #20251294...

Follow

© 2026 National Bureau of Economic Research. All Rights Reserved.

labor impacts nber market citation economics

Related Articles